Physician profile
Robert D Glore
NPI 1255863494
$833.39
in general payments reported to CMS, 2019-2025
12 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $190 · 2023: $99.42 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $172.72 | 2021 | |
| Novo Nordisk INC | $160.96 | 2022-2025 | Ozempic |
| Braeburn INC. | $127.34 | 2025 | Brixadi |
| Janssen Pharmaceuticals, INC | $69.61 | 2021 | |
| Pfizer INC. | $64.85 | 2023 | |
| Exact Sciences Corporation | $55.57 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.45 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.71 | 2022 | |
| W. L. Gore & Associates, INC. | $34.57 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Boston Scientific Corporation | $25.26 | 2021 | |
| Medtronic, INC. | $17.22 | 2021 | |
| Merck Sharp & Dohme LLC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Glore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.